AU4090299A - Liposomal delivery complex - Google Patents
Liposomal delivery complexInfo
- Publication number
- AU4090299A AU4090299A AU40902/99A AU4090299A AU4090299A AU 4090299 A AU4090299 A AU 4090299A AU 40902/99 A AU40902/99 A AU 40902/99A AU 4090299 A AU4090299 A AU 4090299A AU 4090299 A AU4090299 A AU 4090299A
- Authority
- AU
- Australia
- Prior art keywords
- delivery complex
- liposomal delivery
- liposomal
- complex
- delivery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
- A61K47/6913—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome the liposome being modified on its surface by an antibody
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8634798P | 1998-05-20 | 1998-05-20 | |
| US60086347 | 1998-05-20 | ||
| PCT/US1999/011177 WO1999059643A2 (en) | 1998-05-20 | 1999-05-19 | Liposomal delivery complex |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU4090299A true AU4090299A (en) | 1999-12-06 |
Family
ID=22197991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU40902/99A Abandoned AU4090299A (en) | 1998-05-20 | 1999-05-19 | Liposomal delivery complex |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU4090299A (en) |
| WO (1) | WO1999059643A2 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7780882B2 (en) | 1999-02-22 | 2010-08-24 | Georgetown University | Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent |
| US9034329B2 (en) | 1999-02-22 | 2015-05-19 | Georgetown University | Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof |
| EP1154756B1 (en) | 1999-02-22 | 2007-01-03 | Georgetown University | Antibody fragment-targeted immunoliposomes for systemic gene delivery |
| WO2002078608A2 (en) * | 2001-04-02 | 2002-10-10 | Georgetown University | A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent |
| EP2077121B1 (en) | 2003-05-06 | 2011-02-09 | Syntonix Pharmaceuticals, Inc. | Clotting factor VII-Fc chimeric proteins for treatment of a hemostatic disorder |
| TWI353991B (en) * | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
| KR20140135267A (en) | 2006-05-15 | 2014-11-25 | 조지타운 유니버시티 | Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof |
| WO2008033253A2 (en) * | 2006-09-11 | 2008-03-20 | Medtronic, Inc. | Liposome complexes containing pharmaceutical agents and methods |
| EP2100597A3 (en) * | 2008-03-11 | 2009-12-30 | Medtronic, Inc. | Liposome complexes |
| AU2012217728B2 (en) * | 2011-02-15 | 2017-04-27 | Vaxiion Therapeutics, Llc | Therapeutic compositions and methods for antibody and Fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells |
| WO2014055682A1 (en) | 2012-10-02 | 2014-04-10 | Vaxiion Therapeutics, Inc. | Immunomodulatory minicells and methods of use |
| KR102687638B1 (en) | 2015-08-04 | 2024-07-22 | 벡션 테라퓨틱스 엘엘씨 | Ionizing irradiation sterilization of bacterial minicell-based biopharmaceuticals |
| GB2552473A (en) * | 2016-07-21 | 2018-01-31 | Evox Therapeutics Ltd | Surface decoration of extracellular vesicles |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5567432A (en) * | 1991-08-02 | 1996-10-22 | Lau; John R. | Masking of liposomes from RES recognition |
| US6027726A (en) * | 1994-09-30 | 2000-02-22 | Inex Phamaceuticals Corp. | Glycosylated protein-liposome conjugates and methods for their preparation |
| WO1997039735A1 (en) * | 1996-04-24 | 1997-10-30 | Sdg, Inc. | Improved masking of liposomes from res recognition |
| CN1261791A (en) * | 1997-07-02 | 2000-08-02 | Sdg有限公司 | Targeted liposomal constructs for diagnostic and therapeutic uses |
| AU3999699A (en) * | 1998-05-19 | 1999-12-06 | Sdg, Inc. | Targeted liposomal drug delivery system |
-
1999
- 1999-05-19 AU AU40902/99A patent/AU4090299A/en not_active Abandoned
- 1999-05-19 WO PCT/US1999/011177 patent/WO1999059643A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999059643A2 (en) | 1999-11-25 |
| WO1999059643A3 (en) | 2000-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2212300A (en) | Delivery vault | |
| AU1225000A (en) | Combined pharmaceutical estrogen-androgen-progestin | |
| AU3485999A (en) | Neo-tryptophan | |
| AU1409100A (en) | Drugs | |
| AU3089199A (en) | Preparations containing licariin | |
| AU4281999A (en) | Peptide | |
| AU4090299A (en) | Liposomal delivery complex | |
| AU3437799A (en) | City-car | |
| AU3522399A (en) | Carvedilol-galenics | |
| AU3253699A (en) | Myxochelines | |
| AU5407599A (en) | Sphingolipid-desaturase | |
| AUPO759797A0 (en) | Dispenser | |
| AU6793598A (en) | Glycosylceramide-containing liposomes | |
| AU1800100A (en) | Medicinal preparations | |
| AU4214800A (en) | Vesicle associated proteins | |
| AUPO911297A0 (en) | Preparation with dispensing means | |
| AU2609599A (en) | Sensor-coupling | |
| AU3204999A (en) | Futureball | |
| AU2316997A (en) | Liposomal delivery system | |
| AU2069199A (en) | Codelets | |
| AU8333698A (en) | Dispenser | |
| AU1055399A (en) | Rollerboard | |
| AU5223199A (en) | Bathtub-bathseat | |
| AU3265895A (en) | Liposome preparation | |
| AU3347599A (en) | Aeromobile |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |